News · CNBC

Cracking AI trade has Wall Street looking for a hedge. An ex-Citadel quant may have the answer

As CoreWeave shares plunged and dragged much of the AI sector lower, investors are looking for ways to hedge AI risk. Hyperbolic, a 50-person fintech startup led by former Citadel Securities quant Jasper Zhang, runs a spot marketplace for GPU computing power that lets traders buy, sell and control GPU clusters. The company has raised $20 million since its 2022 launch, expects a $150 million annualized run rate by year-end, and says it has about 250,000 users. Meanwhile, CME Group plans a cash-settled futures product tied to GPU pricing from Silicon Data, which is under CFTC review, with the review period extended to November 9th. Hyperbolic's Kim argued that cash futures need physical usage data to stay tied to reality, while Zhang said cash-settled futures alone do not put idle GPUs to work.

Summary written by Upside AI from the original article. Read the source for full details.

Read the original on CNBC ↗

Keywords

artificial intelligencefuturescloud computingCoreWeave

Open a keyword to see other news on the same topic.

Related tickers and likely impact

NVDA

• Neutral

Nvidia

Relevance: low

MarketUS stocks
SectorInformation Technology
IndustrySemiconductors
Market cap$5.1T
Close on 10/23/2026211.00
Change that session-0.57%
NVDA price, forecasts and signals →

Impact is scored by AI from the headline and may be wrong. It is not investment advice.

Related news

Related markets

US stocks →

Latest news

  • Micron Just Delivered a Monster Quarter, but the Stock Is Plummeting. The Reason Is Obvious.

    Micron (MU) posted record fiscal fourth-quarter results, with revenue of $54.2 billion, up nearly 380% year over year, and EPS of $32.87, and guided to $61.5 billion in revenue for fiscal Q1 2027. Despite this, the stock has fallen roughly 20% since the report and was about 29% below its all-time high as of Oct. 22. The article attributes the sell-off to concerns about the sustainability of AI capital spending, high valuations and whether the memory industry's unusually high profitability will last, while the iShares Semiconductor ETF has declined 15% since the report. The author views the forward P/E of about 7 as modest and believes investors may have already priced in considerable downside risk.

    Yahoo Finance·• NVDAMicronearningssemiconductors
  • YYForce Applauds Tesla and Elon Musk on Commencing Manufacturing of Optimus Humanoid Robots

    YYForce Inc. (NASDAQ: YFOR) congratulated Tesla and Elon Musk after Tesla said production of its Optimus humanoid robot has begun in Fremont, California, a phase Tesla describes as early ramp. YYForce plans to deploy its first humanoid robot at Novotel Singapore on Stevens in early November 2026 to evaluate hospitality applications, with the scope depending on technical readiness and initial results. The company stresses that this is a separate initiative: the release announces no partnership or endorsement involving Tesla, and the robot to be deployed is not a Tesla Optimus.

    Yahoo Finance·▲ TSLATSLAElon Muskhumanoid robots
  • Elon Musk predicts many neoclouds will experience 'guppy-level death'

    SpaceX (SPCX) confirmed it has closed a $40 billion finance lease deal for Nvidia (NVDA) AI chips, backed by Apollo. Elon Musk said debt markets have largely stopped lending to neoclouds that rely on revenue to pay for data centers, and that more than 200 neoclouds will see "guppy-level death" through consolidation, with few surviving. The $40 billion deal has not yet priced; Bloomberg reported its debt could price at around 8%, above earlier expectations, while CoreWeave's debt is trading at about 15%. Chamath, an AI bull, also said it will be a consolidation year for a few. The hosts noted Musk's comments may be self-serving, or aimed at talking prices down so he can pick up more computing capacity.

    Yahoo Finance·▼ NVDANVDAElon MuskSpaceX
  • Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady

    Moderna shares fell 7% to $185.74 in morning trading after its personalized melanoma vaccine, intismeran autogene, given with Keytruda, met its primary goal of reducing the risk of recurrence or death, but its effect on distant metastasis was far smaller than an earlier mid-stage study suggested. Detailed late-stage results were released on October 22 ahead of a conference in Madrid. BioNTech fell 3% to $85.65, Merck fell 0.2% to $145.61 and Pfizer fell 0.2% to $29.96, while the iShares Biotechnology ETF rose 0.2% to $208.21. The article notes Moderna's business relies entirely on mRNA medicines, so the vaccine carries a large share of its pipeline value, and says the next step is whether the full dataset supports a regulatory filing.

    Yahoo Finance·Modernapharmaceuticalscancer vaccine
  • HOOD’s prediction markets to add $1.7B to revenue, exceed crypto by 2028: Bernstein

    Bernstein raised its revenue estimates for Robinhood Markets (HOOD) for 2026, 2027 and 2028 by 3%, 4% and 3% respectively, and kept its $160 price target unchanged. The firm expects prediction markets to grow from about $650 million this year to $1.7 billion in 2028, surpassing projected crypto-based revenue of $1.6 billion and accounting for roughly 18% of the projected $9.4 billion in total 2028 revenue. Bernstein expects Q3 revenue to rise 13% quarter over quarter to around $1.5 billion, driven by equity, options and event contract volumes and a recovery in crypto trading. HOOD was set to open lower, with premarket trading at $93.60, and is down more than 29% over the past 12 months.

    Cointelegraph·HOODcryptoprediction markets
  • One Catalyst Could Completely Change the Tesla Stock Story

    The article argues that the unsupervised Robotaxi fleet could decide the Tesla stock story, but its economics have not yet shown up in reported results. The 24/7 Wall St. model sets a price target of $404.84, 8.1% above the $374.58 close on October 22, and rates the stock hold because it sees shares trading near fair value. In Q3, revenue of $28.05 billion and EPS of $0.48 beat estimates, but operating income fell 55.79% as R&D rose to $2.76 billion and battery supply limited deliveries to 486,532 vehicles. Free cash flow dropped 61.63% to $1.53 billion, while management expects about $20 billion in capex this year. Traders put 65.5% odds on a SpaceX merger being announced by the end of 2027.

    Yahoo Finance·• TSLATSLAself-driving carsSpaceX

All news →

Get the briefing on Telegram or Zalo

Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.